Henning R. Stennicke

Chief Tech/Sci/R&D Officer at FREELINE THERAPEUTICS HOLDINGS PLC

57 year

Health Technology

Consumer Services

Profile

Henning R.
Stennicke is currently the Chief Scientific Officer at Freeline Therapeutics Holdings Plc since 2022.
Prior to this, he worked as the Project Vice President-Global Development Biopharm at Novo Nordisk A.
He holds an MBA from the Technical University of Denmark and a graduate degree from the University of Copenhagen.

Henning R. Stennicke active positions

Companies	Position	Start
FREELINE THERAPEUTICS HOLDINGS PLC	Chief Tech/Sci/R&D Officer	01/03/2022

All active positions of Henning R. Stennicke

Former positions of Henning R. Stennicke

Companies	Position	End
NOVO NORDISK A/S	Corporate Officer/Principal	-

See the detail of Henning R. Stennicke's experience

Training of Henning R. Stennicke

University of Copenhagen	Graduate Degree
Technical University of Denmark	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Henning R. Stennicke's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
NOVO NORDISK A/S	Health Technology

Private companies	1
Freeline Therapeutics Holdings Plc Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom.	Health Technology